Micoclear Cream
NDC 57237-350
Product Information
Micoclear (clotrimazole antifungal) is a OTC MONOGRAPH DRUG-approved product labeled by Rising Pharma Holdings, Inc.. This medication is used to treat vaginal yeast infections. It is supplied as a cream for topical administration. This product entry covers the primary NDC 57237-350 and 3 associated package configurations. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 57237-350?
What are the uses of this product?
What are Active Ingredients of this product?
- CLOTRIMAZOLE 10 mg/g - An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- CLOTRIMAZOLE (UNII: G07GZ97H65)
- CLOTRIMAZOLE (UNII: G07GZ97H65) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BENZYL ALCOHOL (UNII: LKG8494WBH)
- CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)
- CETYL PALMITATE (UNII: 5ZA2S6B08X)
- OCTYLDODECANOL (UNII: 461N1O614Y)
- POLYSORBATE 60 (UNII: CAL22UVI4M)
- WATER (UNII: 059QF0KO0R)
- SORBITAN MONOSTEARATE (UNII: NVZ4I0H58X)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 309367 - clotrimazole 1 % Topical Cream
- RxCUI: 309367 - clotrimazole 10 MG/ML Topical Cream
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.